About
Eyebot, founded in 2021 in Boston, USA, develops AI-powered kiosk devices that can perform eye examinations in 90 seconds without the need for an optometrist.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2025-08Series A$20M
Investors · General Catalyst, Village Global, AlleyCorp, Ubiquity Ventures, BaukunstSource · SVTR Weekly #120
- 2024-06New funding round$6M
Investors · AlleyCorp, Susa Ventures, Uniquity Ventures, Spacecadet Ventures, Ravelin, Baukunst, Village GlobalSource · SVTR Weekly #056
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Eyebot
AI-powered kiosks that perform eye exams in 90 seconds without an optometrist
Series A · $26M · 2025-08
$26M
United States
BusinessLatest roundTotal raisedDate- Alloy Therapeutics
Technology-driven biologics R&D infrastructure and antibody discovery platform
Series D+ · $40M · 2026-04 · Valuation $1.0B
$40MValuation $1.0B - Apricity Health
Tech-driven virtual oncology care platform plus Dynamic Precision real-world data drug discovery engine, integrating patient-reported outcomes, EHRs and genomic data; serves cancer patients and care teams, academic cancer centers and pharma companies, using longitudinal patient data to find druggable adaptive resistance mechanisms and companion biomarkers.
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Y Combinator
38 Life Sciences deals in the last 24 months · 33 at a nearby stage · 31 in Boston Metro
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 12 at a nearby stage · 22 in Boston Metro
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 10 at a nearby stage · 20 in Boston Metro
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 6 at a nearby stage · 15 in Boston Metro
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 11 at a nearby stage · 14 in Boston Metro
Request intro →Insight Partners
14 Life Sciences deals in the last 24 months · 8 at a nearby stage · 13 in Boston Metro
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.